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Abstract 
Some new 3,5-diaryl-N-hydroxy-tetrahydro-1,4-thiazine-1,1-dioxides (6a-i) have been synthesized by 
reacting thiazines (4) with dimethyldioxirane (5) and tested for their antibacterial and acute toxicity 
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Introduction 
Molecules with heteroaromatic rings as part 
structures are widely available in nature apart from 
their synthetic viability as valuable compounds.  
Incorporation of heteroatoms within the frame 
work of donor systems has been regarded as an 
important aspect of designing new molecules.  It is 
well known that molecules containing nitrogen, 
sulfur and other members of heteroatoms exhibit a 
variety of biological activities (Katritzky, 1965; 
Prot and Thomson, 1976; Faria et al., 1979).  A 
large group of thiazines, benzothiazines and 
phenothiazines have antihistaminic, antihyper‒ 
‒tensive, diuretic, antipsychotic and antimicrobial 
effects (Matier et al., 1974; Kaverling Busiman, 
1982; Klaus and Erik, 1982; Bertran Katzen, 1995; 
Dayle; Dengle et al., 1999). 
Recently the antiviral activity of benzothia‒   
‒zines against human immuno-deficiency virus-1 
and 2 (HIV-1 and HIV-2) has been reported 
(Duckworth and Handerz, 1991; Seraginoedk et 
al., 1995).   
Similarly, Dimethyldioxirane (DMD) is an 
efficient and powerful electrophilic oxidant 
(Thenmozhiyal et al., 2006) and it is known to 
oxidize primary amines to nitro compounds, 
secondary amines to hydroxylamines and nitrones.  
Heterocyclic hydroxylamines are of much 
importance because of their pharmacological and 
physiological activity.  Many potential central 
nervous system depressants exhibit more activity 
in their N-hydroxylamine form than in their amino 
or N-aryloxy derivatives. 
Baliah and Rangarajan (1954) have 
synthesized 3,5-diaryltetrahydro-1,4-thiazine-1,1-
dioxides and 2,6-dialkoxycarbonyl-3,5-diarylte 
trahydro-1,4-thiazine-1,1-dioxides  by the 
condensation of sulphonyldiacetic acids/ 
sulphonyldiacetates with aryl aldehydes and 
ammonia.  The N-methyl derivatives of substituted 
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tetahydro-1,4-thiazine-1,1-dioxides were synthesized 
by Pandiarajan and Christopher Benny (1994). 
In the present study, the oxidation of di- and 
tetra substituted thiazines (4) using excess 
dimethyldioxirane (5) (in situ) were carried out 
with a view to get N-hydroxy thiazines (6). 
Chemistry 
The N-hydroxy derivatives of 2,6-
diphenylpiperidin-4-ones and N-hydroxy -r-2,c-6-
diphenylpiperidines (Thenmozhiyal et al., 2006) 
were synthesized and characterized by elemental 
analysis and spectral data. 
In the similar way we have synthesized the    
N-hydroxy-1,4-thiazine-1,1-dioxides (6a-i).  This 
transformation is carried out by treating thiazines 
(4) with excess dimethyldioxirane (5) as shown in 
Scheme 1. 
The formation of N-hydroxy compounds (6a-i) 
was confirmed from the IR spectra by the absence 
of N-H stretching bands around 3300 cm-1 in the 
IR spectra and the appearance of medium band in 
the region 3322-3437 cm-1 due to the N-OH 
vibration and the asymmetric and symmetric 
stretching vibrations of the sulfonyl group in the 
region 1322-1349, 1302-1317 and 1115-1146 cm-1.  
Further a singlet around 4.60-4.63 ppm, in the 1H 
NMR spectra also confirms the product. 
It is well known that the C=O group has 
characteristic absorption between 1600-1800 cm-1.  
The C=O absorption depends upon the functional 
group which it is present. The N-hydroxy 
compounds (6d-i), the presence of C=O absorption 
in carbonyls of the ester group was found to be in 
the range of 1628-1656 cm-1. 
The assignments for the six membered 
heterocyclic ring carbons with the side chain 
methylene carbons are made by comparing the 
signals with that of parent thiazine compounds 
(Pandiarajan and Chrisotpher, 1994; Sundari and 
Valliappan, 2004). 
Results and discussion 
In vitro antibacterial activity 
The preliminary antibacterial screening of the 
synthesized compounds was carried out by using 
disc method.  The bacteria viz., Staphylococcus 
aureus (Gram positive) and Klebsiella 
pneumoniae (Gram negative) is used for the study. 
Acetone is used as a control and Norfloxacin is 
used as standard. The antibacterial activity of the 
compounds (6a-i) is given in Table-1. 
Of the compounds tested 6c, 6f and 6i inhibit 
the growth of tested bacteria and fungi at a 
minimum concentration 25μgml-1.  The rest of the 
compounds show inhibition at higher 
concentration ranging from 50 to 80 μgml-1 and 
6a, 6d and 6g do not have inhibition action even at 
200 μgml-1.  6c and 6f showed good activity 
against Staphylococcus aureus.  6b, 6e and 6h 
showed moderate activityand 6a, 6d and 6g 
showed less active when compared to the standard 
Norfloxacin. 
Table 1. Antibacterial activity of compounds (6a-i) 
Compound K. pneumoniae S. aureus
6a 7 9 
6b 11 11 
6c 16 16 
6d 8 8 
6e 10 11 
6f 17 17 
6g 8 7 
6h 11 11 
6i 17 15 
Norfloxacin 22 21 
Zone of inhibition in (mm): inactive < 8 mm; moderate 9-12 
mm; active > 12 mm 
Acute toxicity studies 
Acute toxicity studies were carried out for 
compounds 6c, 6f and 6i using 5 groups of albino 
mice for each compound and each group comprise 
10 animals. 
The LD50 values of the active compounds 
were found to be > 1000 mg/kg b.w.  All the 
compounds were found to be non-toxic to mice 
upto 1000 mg/kg p.o. dose. 
Experimental 
Chemistry 
Thin-layer chromatography (TLC) was used to 
monitor the progress of the reaction and the purity 
of the products. The melting points were recorded 
in open capillaries and are uncorrected. IR spectra 
were recorded in AVATAR-330 FT-IR 
spectrophotometer (Thermo Nicolet) and only 
strong absorption bands (reciprocal centimeters) 
are listed.                                                       
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1H NMR spectra were recorded at 400 MHz on 
BRUKER DRX 400 MHz spectrophotometer; 
CDCl3 was used as solvent and TMS as internal 
standard. 13C NMR spectra were recorded at 100 
MHz on BRUKER DRX 400 MHz spectrometer; 
CDCl3 was used as solvent. Unless otherwise 
stated, all the reagents and solvents used were of 
high grade and purchased from Fluka and Merck. 
All the solvents were distilled before use. The 
abbreviations used to indicate the peak multiplicity 
were: s-singlet; d-doublet; dd-doublet of doublet; 
t-triplet; q-quartet and m-multiplet. 
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Preparation of thiodiglycollic acid (1) 
This compound was prepared by the method 
employed by Bearse (1947).  Monochloroacetic 
acid (94.5 g) was taken in a one litre beaker and 
dissolved in water    (75 ml).  This solution was 
neutralized with saturated sodium carbonate 
solution.A solution of sodium sulphide 
monohydrate (142 g) in water (100 ml) was added 
slowly with constant stirring.  There was 
considerable evolution of heat.  The mixture was 
allowed to stand for 3 hr and filtered to remove the 
small amount of dark green flocculent precipitate.  
Concentrated sulphuric acid (75 ml) was added 
with stirring, keeping the temperature at 25-30°C.  
Ethyl methyl ketone (100 ml) was added to the 
resulting solution and shaken well in a separatory 
funnel.  The ketone layer was drawn off and dried 
over anhydrous sodium sulphate.  The ethyl 
methyl ketone layer was filtered and distilled with 
a recovery of 75 ml of ethyl methyl ketone.  The 
remaining solution in the flask mainly containing a 
concentrated aqueous solution of thiodiglycollic 
acid was poured, while hot, into a beaker and 
cooled in ice water.  The acid soon solidified and 
it was dried and weighed 60 g (80%).  After 
recrystallizing it from hot water, it had a melting 
point of 127-129°C.  Baliah and Rangarajan 
(1954) report the same melting point.   
Preparation of sulphonyldiacetic acid (2) 
Thiodiglycollic acid (1) 100 g was slowly 
added to a solution of hydrogen peroxide (30%, 
300 ml) and glacial acetic acid (5 ml), taken in a 
one litre conical flask.  The rise in temperature 
during the addition of thiodiglycollic acid was 
controlled by cooling the solution in ice water.  
After the addition was complete, the reaction 
mixture was kept at 20°C for 3 hr, then at room 
temperature for 48 hr.  Finally, it was evaporated 
on a steam bath to dryness.  Sulphonyldiacetic 
acid was purified by boiling an aqueous solution 
with decolourising carbon.  The carbon was then 
filtered off and the water was evaporated on a 
steam bath.  The yield was almost theoretical. It 
had a melting point of 182-184°C.   
Preparation of di-n-methyl sulphonyldiacetate/di-
n-ethyl sulphonyldiacetate (3)    
Sulphonyldicetic acid (2) (20 g), methanol/ 
ethanol (75 ml) and sulphuric acid (1 ml) were 
refluxed for 6 hr.  The excess alcohol was 
removed by distillation and the residual solution 
was poured into water (150 ml).  The separated 
ester was taken up in ether and dried (CaCl2); the 
solvent was removed and the residue was distilled, 
giving the ester. 




All the parent di- and tetra- substituted 
tetrahydro-1,4-thiazine-1,1-dioxides were prepared 
according to the procedure of Baliah and 
Rangarajan (1954). A mixture of sulphonyl 
diacetic acid/sulphonyldiacetate (3) (0.02 mol) 
with araldehydes (0.04 mol) and ammonium 
acetate (0.02 mol) were refluxed for 15 minutes.  
There was a brisk evolution of carbon dioxide at 
the beginning but it slowly subsided.  The 
completion of the reaction was indicated by the 
change of colour to brownish yellow.  The 
reaction mixture was cooled and ether 30 ml was 
added.  On shaking well and leaving aside, the 
turbid ethereal layer cleared leaving a small 
aqueous layer below.  The ethereal layer was 
separated; dry hydrogen chloride was passed into 
it.  The precipitated thiazine hydrochloride was 
separated by filtration, washed with ether and 
dried. The free base was liberated by dissolving 
the thiazine hydrochloride in ethanol, adding 
aqueous ammonia and diluting with water.  On 
recrystallizing from ethanol, it melted at 202-
203°C. 




The respective thiazines (4) (5 mmol) in 
dichloromethane (40 ml) and acetone (80 ml) was 
kept at 0°C in an ice bath for freshly prepared 
solution of dimethyldioxirane (5) (oxone) (6.14 g, 
100 mmole) in water (25 ml) was added in drops 
for a period of 1 hr with constant stirring.  The pH 
was maintained between 7.0-8.0 by adding drops 
of potassium hydroxide solution. The reaction 
mixture was allowed to stir vigorously for about 
40 minutes.  After the separation of 
dichloromethane layer, the aqueous layer was 
extracted with two 50 ml portions of 
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dichloromethane the combined dichloromethane 
extract was washed with water, dried over 
anhydrous sodium sulphate, filtered and 
evaporated.  The solid left behind was 
recrystallized from 1:2 mixture of benzene and 
petroleum ether (60-80°C) to get colourless 
crystals of N-hydroxy derivative.   
3,5-diphenyl-N-hydroxy-tetrahydro-1,4-thiazine 
-1,1-dioxide (6a).  
m.p. 219-221ºC, yield 70%. IR: νmax (KBr, cm-1): 
3327 (N-OH), 1348, 1302, 1146 (SO2). 1H-NMR 
(400 MHz, CDCl3)  δH: 3.10-3.21 (H-2 & H-6) (m, 
4H),  4.40 (H-3 & H-5) (t, 2H),  4.60 (N-OH) (s, 
1H), 7.25-7.45 (m, 10H, -Ar-H). 13C-NMR (100 
MHz, CDCl3) δC:  58.41 (C-2 & C-6), 59.06 (C-3 
& C-5), 126.70, 128.70, 129.00, 140.30. Anal. 
Calcd. for C16H17NO3S: C, 63.34; H, 5.65; N, 4.62 
%. Found:  C, 63.44; H, 5.69; N, 4.67 %. Mass 
spectrum EIMS (M+): 303. 
3,5-bis(p-methoxyphenyl)-N-hydroxy-tetrahydro 
-1,4-thiazine-1,1-dioxide (6b).  
m.p. 222-224ºC, yield 50%. IR: νmax (KBr, cm-1): 
3331 (N-OH), 1342, 1309, 1131 (SO2). 1H-NMR 
(400 MHz, CDCl3)  δH: 3.12 (H-2 & H-6) (dd, 
4H),  3.80 (OCH3) (s, 6H), 4.35 (H-3 & H-5) (t, 
2H),  4.60 (N-OH) (s, 1H), 6.38 (H-3’ & H-5’) (d, 
4H, J = 8.8 Hz, -Ar-H), 7.35 (H-2’ & H-6’) (d, 4H, 
J = 8.8 Hz, -Ar-H). 13C-NMR (100 MHz, CDCl3) 
δC:  55.27 (C-2 & C-6), 53.27 (OCH3), 58.39 (C-3 
& C-5), 116.22, 131.78, 135.07, 159.16. Anal. 
Calcd. for C18H21NO5S: C, 59.49; H, 5.82; N, 3.85 
%. Found:  C, 55.69; H, 5.92; N, 3.88 %. Mass 
spectrum EIMS (M+): 363. 
3,5-bis(p-chlorophenyl)-N-hydroxy-tetrahydro-
1,4-thiazine-1,1-dioxide (6c). 
m.p. 225-227ºC, yield 62%. IR: νmax (KBr, cm-1): 
3340 (N-OH), 1344, 1305, 1140 (SO2). 1H-NMR 
(400 MHz, CDCl3)  δH: 3.10- 3.13 (H-2 & H-6) 
(m, 4H),  4.41 (H-3 & H-5) (t, 2H),  4.61 (N-OH) 
(s, 1H), 7.20-7.40 (m, 8H, -Ar-H). 13C-NMR (100 
MHz, CDCl3) δC:  55.22 (C-2 & C-6), 58.49 (C-3 
& C-5), 114.22, 132.78, 134.06, 159.66. Anal. 
Calcd. for C16H15NO3SCl2: C, 51.62; H, 4.06; N, 
3.76 %. Found:  C, 51.72; H, 4.10; N, 3.82 %. 
Mass spectrum EIMS (M+): 372. 
2,6-dimethoxycarbonyl-3,5-diphenyl-N-hydroxy 
-tetrahydro-1,4-thiazine-1,1-dioxide (6d).  
m.p. 230-232ºC, yield 70%. IR: νmax (KBr, cm-1): 
3322 (N-OH), 1645 (C=O), 1335, 1308, 1128 
(SO2). 1H-NMR (400 MHz, CDCl3)  δH: 3.52 
(COOCH3) (s, 6H), 4.21 (H-2 & H-6) (d, 2H),  
4.74 (H-3 & H-5)   (d, 2H),  4.60 (N-OH) (s, 1H), 
7.20-7.50 (m, 10H, -Ar-H). 13C-NMR (100 MHz, 
CDCl3) δC:  53.21 (COOCH3), 59.21 (C-3 & C-5), 
69.92 (C-2 & C-6), 127.63, 128.40, 138.98, 163.70 
(C=O). Anal. Calcd. for C20H21NO7S: C, 57.27; H, 
5.05; N, 3.34 %. Found:  C, 57.38; H, 5.15; N, 




m.p. 225-227ºC, yield 52%. IR: νmax (KBr, cm-1): 
3340 (N-OH), 1628 (C=O), 1348, 1305, 1125 
(SO2). 1H-NMR (400 MHz, CDCl3)  δH: 3.54 
(COOCH3), (s, 6H), 3.80 (OCH3) (s, 6H), 4.27 (H-
2 & H-6) (d, 2H),  4.63 (N-OH) (s, 1H), 4.70 (H-3 
& H-5) (d, 2H),  6.80 (H-3’ & H-5’) (d, 4H, J = 
7.8 Hz, -Ar-H), 7.35 (H-2’ & H-6’) (d, 4H, J = 7.8 
Hz, -Ar-H). 13C-NMR (100 MHz, CDCl3) δC: 
52.41 (OCH3),  53.13 (COOCH3), 59.94 (C-3 & 
C-5), 69.96 (C-2 & C-6), 114.01, 132.01, 134.41, 
159.00, 164.02 (C=O). Anal. Calcd. for 
C22H24NO9S: C, 55.11; H, 5.26; N, 2.92 %. Found:  
C, 55.20; H, 5.30; N, 3.00 %. Mass spectrum 




m.p. 235-237ºC, yield 75%. IR: νmax (KBr, cm-1): 
3327 (N-OH), 1690 (C=O), 1332, 1309, 1135 
(SO2). 1H-NMR (400 MHz, CDCl3)  δH: 3.52 
(COOCH3), (s, 6H), 4.22 (H-2 & H-6) (d, 2H),  
4.62 (N-OH) (s, 1H), 4.72 (H-3 & H-5) (d, 2H),  
7.25-7.40 (m, 8H, -Ar-H). 13C-NMR (100 MHz, 
CDCl3) δC: 53.43 (COOCH3), 58.92 (C-3 & C-5), 
69.16 (C-2 & C-6), 114.71, 132.91, 136.43, 
158.70, 162.42 (C=O). Anal. Calcd. for 
C20H19NO7SCl2: C, 49.19; H, 3.92; N, 2.87 %. 
Found:  C, 49.29; H, 3.99; N, 2.95 %. Mass 
spectrum EIMS (M+): 488. 
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 m.p. 197-199ºC, yield 65%. IR: νmax (KBr, 
cm-1): 3437 (N-OH), 1634 (C=O), 1349, 1312, 
1115 (SO2). 1H-NMR (400 MHz, CDCl3)  δH: 1.20 
(COOCH2CH3), (t, 3H, J = 7.2 Hz), 4.10 
(COOCH2CH3) (q, 2H, J = 7.2 Hz), 4.19 (H-2 & 
H-6) (d, 2H),  4.61 (N-OH)    (s, 1H), 4.73 (H-3 & 
H-5) (d, 2H), 7.23-7.38 (m, 10H, -Ar-H). 13C-
NMR (100 MHz, CDCl3) δC: 13.54 
(COOCH2CH3), 61.01 (C-3 & C-5), 61.04 
(COOCH2CH3), 65.94 (C-2 & C-6), 126.14, 
134.91, 136.43, 159.72, 167.26 (C=O). Anal. 
Calcd. for C22H25NO7S: C, 59.05; H, 5.63; N, 3.13 
%. Found:  C, 59.15; H, 5.69; N, 3.18 %. Mass 




 m.p. 192-194ºC, yield 53%. IR: νmax (KBr, 
cm-1): 3410 (N-OH), 1628 (C=O), 1336, 1310, 
1120 (SO2). 1H-NMR (400 MHz, CDCl3)  δH: 1.21 
(COOCH2CH3), (t, 3H, J = 7.2 Hz), 3.80 (OCH3) 
(s, 6H), 4.13 (COOCH2CH3) (q, 2H, J = 7.2 Hz), 
4.24 (H-2 & H-6) (d, 2H),  4.62 (N-OH) (s, 1H), 
4.73 (H-3 & H-5) (d, 2H), 6.80 (H-3’ & H-5’) (d, 
4H,  J = 7.8 Hz,-Ar-H), 7.32 (H-2’ & H-6’) (d, 4H, 
J = 7.8 Hz,-Ar-H). 13C-NMR (100 MHz, CDCl3) 
δC: 13.01 (COOCH2CH3), 55.05 (OCH3), 62.03  
(COOCH2CH3), 62.41 (C-3 & C-5), 69.82 (C-2 & 
C-6), 126.74, 134.92, 136.74, 159.41, 167.62 
(C=O). Anal. Calcd. for C24H29NO9S: C, 56.79; H, 
5.76; N, 2.76 %. Found:  C, 56.88; H, 5.79; N, 




 m.p. 190-192ºC, yield 55%. IR: νmax (KBr, 
cm-1): 3430 (N-OH), 1656 (C=O), 1345, 1317, 
1121 (SO2). 1H-NMR (400 MHz, CDCl3)  δH: 1.22 
(COOCH2CH3), (t, 3H, J = 7.2 Hz), 4.09 
(COOCH2CH3) (q, 2H, J = 7.2 Hz), 4.20 (H-2 & 
H-6)  (d, 2H),  4.62 (N-OH) (s, 1H), 4.70 (H-3 & 
H-5) (d, 2H), 7.25-7.38 (m, 8H, -Ar-H). 13C-NMR 
(100 MHz, CDCl3) δC: 13.64 (COOCH2CH3), 
61.01 (COOCH2CH3), 62.62 (C-3 & C-5), 69.34      
(C-2 & C-6), 124.72, 133.22, 136.54, 159.89, 
167.82 (C=O). Anal. Calcd. for C22H23NO7SCl2: 
C, 51.17; H, 4.49; N, 2.71 %. Found:  C, 51.29; H, 
4.60; N, 2.80 %. Mass spectrum EIMS (M+): 516. 
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